Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital)

• Conditions: Covid-19

• Registration Number: NCT04528901
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

seroPREvalence vis-à-vis SARS-CoV2 and correlation with clinical forms of COVID-19 in patients followed in Pulmonology in the cluster area of the Grand-Est region.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2020-08-25
• Study First Submitted QC: 2020-08-25
• Study First Posted: 2020-08-27
• Status Verified: 2020-09
• Study Start: 2020-09-04
• Last Update Submitted: 2021-01-26
• Last Update Posted: 2021-01-27
• Primary Completion: 2022-12
• Study Completion: 2022-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 1080

Inclusion Criteria

• Man or woman from 18 years old and without upper age limit

• Patient followed in pulmonology at Strasbourg University Hospital

• Patient presenting at least one of the following pathologies:

  1. severe persistent asthma (200 patients)
  2. chest cancer that is active or has received treatment within a period of less than one year (300 patients)
  3. history of lung transplantation performed before the start of the epidemic (02/29/2020) (300 patients)
  4. idiopathic or other diffuse interstitial lung disease, sarcoidosis or vasculitis (70 patients)
  5. pulmonary arterial hypertension (PAH) (group 1 of the international classification) any cause or chronic thromboembolic PAH (group 4): (60 patients)
  6. Severe COPD in the respiratory failure stage (150 patients)

• Subject affiliated to a social health insurance protection scheme

• Subject able to understand the objectives of the research

• Subject having signed an informed consent

Exclusion Criteria

• Inability to provide informed information about the subject (subject in an emergency situation, difficulty in understanding the subject, etc.)
• Subject under safeguard of justice
• Subject under guardianship or guardianship

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Determine and compare the seroprevalence for SARS-CoV2 among patients with respiratory pathologies monitored in Pneumology at the Strasbourg University Hospital, in the cluster zone of the Grand Est.	15 months	Carrying out a serological assay of specific antibodies to SARS-CoV-2

Trial Locations

Locations (1)

Les Hôpitaux Universitaires de Strasbourg; 🇫🇷 Strasbourg, Bas-Rhin, France